The latest cancer news for cancer research. Inform yourselves about the newest technologies, best practices and studies in the field of cancer diseases and tumors.

• Slow electrons to combat cancer August 22, 2019
  Slow electons can be used to destroy cancer cells - but how exactly this happens has not been well understood. Now scientists have been able to demonstrate that a previously little-observed effect actually plays a pivotal role: Due to a process called interatomic Coulombic decay, an ion can pass on additional energy to surrounding atoms. This frees a huge nu […]
• Enzyme that helps protect us from stress linked to liver cancer growth August 22, 2019
  An enzyme induced by stress to help reduce production of damaging free radicals is also used by liver cancer to regulate two major cell proliferation pathways that enable the cancer to thrive, scientists report.
• New pathway for potential glioblastoma treatment August 21, 2019
  A team has discovered a new pathway that may help suppress the development of glioblastoma tumors, one of the deadliest forms of cancer.
• Researchers convert pro-tumor macrophages into cancer killers August 21, 2019
  Researchers identified a new therapeutic approach in mouse models that halts drug resistance and cancer progression by using an antibody that induces the immune system via macrophages to seek and kill cancer cells.
• 'Kissing loops' in RNA molecule essential for its role in tumor suppression August 21, 2019
  Researchers have discovered that the tumor suppressor MEG3 adopts a complex three-dimensional structure to fulfill its function. Furthermore, they were able to fine-tune its activity by targeted manipulation of this architecture. The results of this study might help to advance diagnosis and treatment of certain types of cancer.
• New drug target for glioblastoma August 21, 2019
  A new international study has identified a new drug target for treating glioblastoma. This target is part of a never-before defined cellular pathway found to contribute to the spread and proliferation of a dangerous subset of cancer cells, called glioma stem cells.
• It's Fab! A hidden touch of antibody August 21, 2019
  Antibodies are key players in our immune system and have been used as biopharmaceuticals. The collaborative groups including researchers have found previously unknown contact sites in the antibody molecule that are involved in its binding to a cognate receptor, challenging the traditional paradigm of the molecular mechanism of antibody function.